Results of a 5-week schedule of modern total skin electron beam radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 86, Issue 5, 2013, Pages 936-941

  Morris, Stephen Lloyd ^a   McGovern, Mark ^a   Bayne, Sally ^a   Wain, Mary ^a   Child, Fiona ^a   Whittaker, Sean ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT TREATMENT; COMBINATION TREATMENTS; COMPLETE RESPONSE; OVERALL SURVIVAL; PROGNOSTIC FACTORS; RESEARCH DATABASE; SYSTEMIC THERAPY; TOTAL SKIN ELECTRON BEAMS;

ELECTRON BEAMS; RADIOTHERAPY;

SURVEYS;

PSORALEN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; FEMALE; FOLLOW UP; HUMAN; MALE; MODERN TOTAL SKIN ELECTRON BEAM RADIATION THERAPY; MYCOSIS FUNGOIDES; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SCORING SYSTEM; SKIN SURFACE; SKIN TUMOR; SYSTEMIC THERAPY; TOTAL SKIN ELECTRON THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION;

DOSE FRACTIONATION; ELECTRONS; FEMALE; HUMANS; MALE; MYCOSIS FUNGOIDES; PROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 84880036625     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.04.042     Document Type: Article

References (20)

1. P.T. Bradford, S.S. Devesa, and W.F. Anderson Cutaneous lymphoma incidence patterns in the United States: A population-based study of 3884 cases Blood 113 2009 5064 5073
2. R. Willemze, E.S. Jaffe, and G. Burg WHO-EORTC classification for cutaneous lymphomas Blood 105 2005 3768 3785 (Pubitemid 40656118)
3. W. Scholtz Ueber den einfluss der rontgenstrahlen auf die haut in gesunden und krankem zustande Arch Dermat U Syph 59 1902 421
4. S.J. Whittaker, J.R. Marsden, and M. Spittle Joint British Association of Dermatologists and UK Cutaneous Lymphoma Group Guidelines for the Management of Primary Cutaneous T-cell Lymphoma Br J Dermatol 149 2003 1095 1107 (Pubitemid 38058085)
5. C.J. Karzmark, R. Loevinger, and R.E. Steele A technique for large-field, superficial electron therapy Radiology 74 1960 633 644
6. L. Szur, J.A. Silvester, and D.K. Bewley Treatment of the whole body surface with electrons Lancet 1 1962 1373 1377
7. AAPM Report No. 23. Total Skin Electron Therapy: Technique and Dosimetry. Repost of Task Group 30 Radiation Therapy Committee AAPM 1988 American Association of Physicists in Medicine College Park, MD
8. G.W. Jones, B.M. Kacinski, and L.D. Wilson Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group J Am Acad Dermatol 47 2002 364 370
9. E.A. Olsen, S. Whittaker, and Y.H. Kim Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: A consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer J Clin Oncol 29 2011 2598 2607
10. D. Navi, N. Riaz, and Y.S. Levin The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides Arch Dermatol 147 2011 561 567
11. L.D. Wilson Delivery and sequelae of total skin electron beam radiotherapy Arch Dermatol 139 2003 812 813 (Pubitemid 36705958)
12. S. Hasham, P. Matteucci, and P. Stanley Necrotising fasciitis clinical review BMJ 330 2005 1143
13. P.A. Quirós, G.W. Jones, and B.M. Kacinski Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides) Int J Radiat Oncol Biol Phys 38 1997 1027 1035 (Pubitemid 27353683)
14. M. Duvic, A.G. Martin, and Y. Kim Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma Arch Dermatol 137 2001 581 593 (Pubitemid 32458440)
15. M.L. Vegna, G. Papa, and D. Defazio Interferon alpha-2a in cutaneous T-cell lymphoma Eur J Haematol Suppl 52 1990 32 35 (Pubitemid 20375387)
16. U. Wollina, R. Dummer, and N.H. Brockmeyer Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma Cancer 98 2003 993 1001 (Pubitemid 37022100)
17. M. Duvic, K. Hymes, and P. Heald Bexarotene Worldwide Study Group. Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: Multinational phase II-III trial results J Clin Oncol 19 2001 2456 2471 (Pubitemid 32391217)
18. C. Harrison, J. Young, and D. Navi Revisiting low-dose total skin electron beam therapy in mycosis fungoides Int J Radiat Oncol Biol Phys 81 2011 e651 e657
19. M. Kamstrup, L. Specht, and G. Skovgaard A prospective, open-label study of low-dose total skin electron beam therapy in mycosis fungoides Int J Radiat Oncol Biol Phys 71 2008 1204 1207
20. M. Duvic, M. Donato, and B. Dabaja Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome J Clin Oncol 28 2010 2365 2372